Two Sigma Advisers’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-231,500
| Closed | -$3.44M | – | 1776 |
|
|
2025
Q4 | $3.44M | Buy |
231,500
+115,900
| +100% | +$1.64M | 0.01% | 975 |
|
|
2025
Q3 | $1.48M | Buy |
+115,600
| New | +$1.54M | ﹤0.01% | 1270 |
|
|
2025
Q2 | – | Sell |
-15,500
| Closed | -$259K | – | 2516 |
|
|
2025
Q1 | $259K | Buy |
+15,500
| New | +$285K | ﹤0.01% | 2044 |
|
|
2024
Q4 | – | Sell |
-12,621
| Closed | -$237K | – | 2504 |
|
|
2024
Q3 | $237K | Sell |
12,621
-57,721
| -82% | -$1.11M | ﹤0.01% | 2007 |
|
|
2024
Q2 | $1.33M | Sell |
70,342
-170,196
| -71% | -$2.9M | ﹤0.01% | 1407 |
|
|
2024
Q1 | $3.91M | Buy |
240,538
+26,727
| +13% | +$391K | 0.01% | 879 |
|
|
2023
Q4 | $2.71M | Buy |
213,811
+171,680
| +407% | +$2.17M | 0.01% | 1116 |
|
|
2023
Q3 | $574K | Sell |
42,131
-16,890
| -29% | -$261K | ﹤0.01% | 1747 |
|
|
2023
Q2 | $1.01M | Sell |
59,021
-14,105
| -19% | -$219K | ﹤0.01% | 1529 |
|
|
2023
Q1 | $1.02M | Sell |
73,126
-20,416
| -22% | -$300K | ﹤0.01% | 1621 |
|
|
2022
Q4 | $1.25M | Sell |
93,542
-1,485
| -2% | -$19.2K | ﹤0.01% | 1469 |
|
|
2022
Q3 | $1.13M | Sell |
95,027
-10,951
| -10% | -$156K | ﹤0.01% | 1462 |
|
|
2022
Q2 | $1.35M | Sell |
105,978
-12,620
| -11% | -$162K | ﹤0.01% | 1437 |
|
|
2022
Q1 | $1.53M | Sell |
118,598
-21,344
| -15% | -$282K | ﹤0.01% | 1401 |
|
|
2021
Q4 | $2.22M | Sell |
139,942
-8,167
| -6% | -$139K | 0.01% | 1143 |
|
|
2021
Q3 | $2.89M | Buy |
148,109
+28,211
| +24% | +$560K | 0.01% | 1060 |
|
|
2021
Q2 | $2.73M | Sell |
119,898
-7,980
| -6% | -$166K | 0.01% | 1143 |
|
|
2021
Q1 | $2.35M | Sell |
127,878
-26,541
| -17% | -$435K | 0.01% | 1194 |
|
|
2020
Q4 | $2.3M | Sell |
154,419
-92,243
| -37% | -$1.2M | 0.01% | 1188 |
|
|
2020
Q3 | $2.77M | Sell |
246,662
-63,476
| -20% | -$625K | 0.01% | 1005 |
|
|
2020
Q2 | $2.46M | Buy |
310,138
+38,791
| +14% | +$321K | 0.01% | 1106 |
|
|
2020
Q1 | $2.19M | Buy |
271,347
+209,171
| +336% | +$2.49M | 0.01% | 1064 |
|
|
2019
Q4 | $782K | Buy |
+62,176
| New | +$670K | ﹤0.01% | 1679 |
|
|
2019
Q3 | – | Sell |
-63,290
| Closed | -$541K | – | 2372 |
|
|
2019
Q2 | $541K | Sell |
63,290
-75,168
| -54% | -$594K | ﹤0.01% | 1778 |
|
|
2019
Q1 | $1.05M | Buy |
138,458
+108,948
| +369% | +$876K | ﹤0.01% | 1506 |
|
|
2018
Q4 | $244K | Buy |
+29,510
| New | +$282K | ﹤0.01% | 2062 |
|
|
2018
Q3 | – | Sell |
-28,211
| Closed | -$276K | – | 2371 |
|
|
2018
Q2 | $276K | Sell |
28,211
-4,455
| -14% | -$43.7K | ﹤0.01% | 2122 |
|
|
2018
Q1 | $304K | Buy |
+32,666
| New | +$311K | ﹤0.01% | 2008 |
|
|
2016
Q3 | – | Sell |
-318,499
| Closed | -$1.86M | – | 2299 |
|
|
2016
Q2 | $1.86M | Sell |
318,499
-144,768
| -31% | -$959K | 0.01% | 892 |
|
|
2016
Q1 | $2.95M | Sell |
463,267
-19,117
| -4% | -$103K | 0.02% | 653 |
|
|
2015
Q4 | $3.1M | Buy |
482,384
+5,012
| +1% | +$31.3K | 0.02% | 608 |
|
|
2015
Q3 | $2.77M | Sell |
477,372
-77,024
| -14% | -$571K | 0.02% | 640 |
|
|
2015
Q2 | $4.84M | Sell |
554,396
-55,309
| -9% | -$465K | 0.04% | 494 |
|
|
2015
Q1 | $4.87M | Sell |
609,705
-62,362
| -9% | -$466K | 0.04% | 499 |
|
|
2014
Q4 | $5.21M | Sell |
672,067
-202,118
| -23% | -$1.47M | 0.04% | 477 |
|
|
2014
Q3 | $5.67M | Sell |
874,185
-115,072
| -12% | -$889K | 0.04% | 462 |
|
|
2014
Q2 | $8.31M | Sell |
989,257
-58,464
| -6% | -$453K | 0.07% | 331 |
|
|
2014
Q1 | $7.03M | Buy |
1,047,721
+336,678
| +47% | +$2.04M | 0.06% | 329 |
|
|
2013
Q4 | $4.45M | Buy |
711,043
+160,915
| +29% | +$786K | 0.04% | 419 |
|
|
2013
Q3 | $2.39M | Sell |
550,128
-88,588
| -14% | -$405K | 0.03% | 559 |
|
|
2013
Q2 | $2.82M | Buy |
+638,716
| New | +$2.83M | 0.04% | 397 |
|
Other funds holding SEM
GCL
Two Sigma Advisers's SEM Position: Q1 2026 in Review
Two Sigma Advisers sold out of Select Medical (SEM) in Q1 2026, closing a stake of 231,500 shares — an estimated $3.44M sold.
Two Sigma Advisers first reported a position in SEM in Q2 2013 and held it in 41 quarters. The position peaked at $8.31M in Q2 2014. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Two Sigma Advisers reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 231,500 Select Medical shares in Q1 2026, an estimated $3.44M.
- Two Sigma Advisers first reported a position in Select Medical in Q2 2013 and held it in 41 quarters.
- Two Sigma Advisers's Select Medical position peaked at $8.31M in Q2 2014.
- 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.